ID: ALA2046559

Max Phase: Preclinical

Molecular Formula: C38H50O9

Molecular Weight: 650.81

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cc1

Standard InChI:  InChI=1S/C38H50O9/c1-23(2)24(3)20-33(41)47-31-22-30-34(5)16-15-29(46-32(40)13-10-26-8-11-28(45-7)12-9-26)21-27(34)14-17-37(30,43)38(44)19-18-36(42,25(4)39)35(31,38)6/h8-14,20,23,29-31,42-44H,15-19,21-22H2,1-7H3/b13-10+,24-20+/t29-,30+,31+,34-,35+,36+,37-,38+/m0/s1

Standard InChI Key:  SEXRIOKVROQFNA-GAKBQJCISA-N

Associated Targets(Human)

Toll-like receptor 4 970 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

AD293 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Toll-like receptor 3 331 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Toll-like receptor 2 975 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nuclear factor NF-kappa-B p65 subunit 627 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NF-kappaB inhibitor alpha 187 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

THP-1 11052 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nuclear factor NF-kappa-B p100/p49 subunits 8 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis B virus 7925 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 650.81Molecular Weight (Monoisotopic): 650.3455AlogP: 5.26#Rotatable Bonds: 8
Polar Surface Area: 139.59Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.39CX Basic pKa: CX LogP: 5.19CX LogD: 5.19
Aromatic Rings: 1Heavy Atoms: 47QED Weighted: 0.20Np Likeness Score: 2.31

References

1. Wang LJ, Geng CA, Ma YB, Luo J, Huang XY, Chen H, Zhou NJ, Zhang XM, Chen JJ..  (2012)  Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents.,  54  [PMID:22687441] [10.1016/j.ejmech.2012.05.012]
2. Huang LJ, Chen SR, Yuan CM, Gu W, Guo BJ, Wang YT, Wang Y, Hao XJ..  (2017)  C21-steroidal pregnane sapogenins and their derivatives as anti-inflammatory agents.,  25  (13): [PMID:28506585] [10.1016/j.bmc.2017.04.045]

Source